In order to implement the sustainable expansion strategy of the internationally renowned LipoClinic Group, which specialises in the treatment of lipedema, Dr Falk-Christian Heck sold his shares in a share deal to Invision, a globally active investment company for growth financing. Part of the transaction is a (re-)participation model through which Dr Heck will continue to hold a significant stake in the company. He will thus be able to control the integration into Invision's structures and the further expansion strategy of the LipoClinic Group.
It is not only the extremely short period of time in which the very complex transaction was fully implemented that should be emphasised. Rather, among the large number of bidders, it was possible to gain a strong strategic partner in Invision, which not only fully shares the same ideas with regard to the continuation of the current business operations, but also the visionary further development of the business field.
About the LipoClinic Group:
The LipoClinic Group was founded by Dr Falk-Christian Heck in Mülheim and, with locations in Mülheim an der Ruhr, Hamburg and Salzburg, is one of the leading medical providers in lipedema treatment.
On behalf of LipoClinic Management GmbH or Dr. Falk-Christian Heck:
Luther, Corporate/M&A: Dr Oliver Kairies (Partner), Dr Thomas Kuhnle (Partner), Dr Daniel Schubmann (Counsel), Dr Karina Wojtowicz (Senior Associate), Stefan Hubertus Tolksdorf (Associate)
Luther, Medical Law: Dr Hendrik Bernd Sehy (Counsel)
Luther, Employment Law: Dr Hilmar Rölz, MLE (Senior Associate), Lukas Beismann (Associate)
Luther, Tax Law: Dr Zacharias-Alexis Schneider, LL.B., LL.M. (Partner)
Luther, Antitrust Law: Dr Helmut Janssen, LL.M. (Partner)
Luther, Capital Markets, Banking & Finance: Christoph Schauenburg, LL.M. (Partner)
Luther, Commercial & Distribution Law, Product Liability/Product Compliance: Dr Kuuya Chibanguza, LL.B. (Partner)
Luther, IT Law: Dr Detlef Mäder (Partner), Dr Katharina Preuss (Senior Associate
